Viewing Study NCT04637204


Ignite Creation Date: 2025-12-24 @ 7:50 PM
Ignite Modification Date: 2026-02-04 @ 11:37 AM
Study NCT ID: NCT04637204
Status: COMPLETED
Last Update Posted: 2021-02-01
First Post: 2020-11-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Real-world Treatment Patterns and Outcomes Among aRCC Patients on Cabozantinib or Axitinib in England
Sponsor: Ipsen
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Renal Cell Carcinoma View
Keywords: